Digestive tract bleeding of liver cancer can be treated by supplementing blood volume, medication and surgery. ⒈ supplementing blood volume: if liver cancer patients lead to large amount of chemotaxis bleeding, it is necessary to establish infusion access, intravenous fluid supplementation and blood transfusion as soon as possible to actively supplement blood volume for patients. ⒈ medication: if liver cancer digestive tract bleeding leads to non-variceal rupture bleeding, acid-suppressing drugs, such as proton pump inhibitors, H2 receptor antagonists, etc.; if it leads to variceal rupture bleeding, vasoactive drugs, such as growth inhibitors, octreotide, terlipressin, etc., need to be given. ③Surgical treatment: gastrointestinal bleeding of liver cancer can also be treated with transjugular intrahepatic portal-body vein stent shunt, which can effectively stop bleeding. If the bleeding is caused by esophagogastric fundus varices, triple-lumen and double-bladder tubes can also be put in to stop bleeding. Patients with gastrointestinal bleeding of liver cancer should actively treat the primary disease and strictly observe their own condition, and inform the doctor in time if they feel unwell to avoid adverse effects.